Teva's Suit Over Aricept Infringement Tossed

Law360, New York (September 11, 2009, 6:27 PM EDT) -- A federal judge has dismissed a declaratory judgment suit filed by Teva Pharmaceuticals Inc. and its Gate Pharmaceuticals division seeking a determination that they did not infringe four patents covering Eisai Co. Ltd.'s blockbuster Alzheimer's drug Aricept.

In a ruling handed down Sept. 10 in the U.S. District Court for the District of New Jersey, Judge Garrett E. Brown Jr. found that Teva did not risk a lawsuit from Eisai or face the threat that the U.S. Food and Drug Administration would block its abbreviated new...
To view the full article, register now.